<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>GBI - China pharma, biotech, and health news</title><link>http://www.gbipharma.com</link><description></description><language>en-us</language><copyright>Copyright 2007 Generalbiologic</copyright><lastBuildDate>Fri, 22 Jul 2011 08:33:03  +0800</lastBuildDate><image><title>GBI - China pharma, biotech, and health news</title><url>http://www.gbipharma.com/google-pic.jpg</url><link>http://www.gbipharma.com</link></image><item><title>State issues guideline to preserve TCM departments in general hospitals </title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The State Administration of Chinese Traditional Medicine has formulate......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Fri, 27 May 2011 17:41:10  +0800</pubDate></item><item><title>Xi'an releases major health reform task plan </title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The municipal government of Xi'an has recently released its major medi......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Fri, 27 May 2011 17:04:24  +0800</pubDate></item><item><title>Hangzhou to list rabies vaccine in the city's reimbursement scheme</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Hangzhou Center for Disease Control and Prevention in Zhejiang pro......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Fri, 27 May 2011 14:31:02  +0800</pubDate></item><item><title>Beijing Tongrentang plans to take majority ownership of TCID </title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Beijing Tongrentang Company Ltd. (SHA: 600085) plans to own majority s......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Fri, 27 May 2011 10:43:55  +0800</pubDate></item><item><title>Wuhan Humanwell completes acquisition of Beijing Manuo Biotech</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Wuhan Humanwell Healthcare (Group) Company Ltd. (CH: 600079) announced......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 26 May 2011 17:32:48  +0800</pubDate></item><item><title>Beijing-based CRO lab gets Netherlands compliance endorsement</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Contract research organization (CRO) MicroConstants China Inc. announc......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 26 May 2011 17:06:34  +0800</pubDate></item><item><title>MOH increases gov't subsidy for basic public health services by 67%</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Chinese Ministry of Health (MOH) has recently announced it raised ......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 26 May 2011 16:41:41  +0800</pubDate></item><item><title>MOH requires reporting of found serious ADRs events within 15 days</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Chinese Ministry of Health (MOH) has recently revised and issued a......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 26 May 2011 15:54:27  +0800</pubDate></item><item><title>SFDA-affiliated Institute forecasts RMB67b pediatric drug sales by 2015</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Southern Medicine Economic Institute under the State Food and Drug......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Thu, 26 May 2011 14:21:05  +0800</pubDate></item><item><title>Xinjiang FDA signs regulatory compliance pact with 110 local retailers </title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Xinjiang (Kashgar) Food and Drug Administration and 110 pharmaceut......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 25 May 2011 16:50:53  +0800</pubDate></item><item><title>Chinese experts introduce new drug repositioning/ADR detector web server</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>In collaboration with the US Food and Drug Administration (FDA), Chine......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 25 May 2011 15:10:47  +0800</pubDate></item><item><title>MOH releases 8 new clinical pathways for opthalmic indications</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Chinese Ministry of Health (MOH) recently issued eight new clinica......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Wed, 25 May 2011 14:30:42  +0800</pubDate></item><item><title>Taiji sells 1% of Southwest Pharmaceutical equity stake</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>Chongqing Taiji Industry Group Company Ltd. (SHA: 600129) has recently......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 24 May 2011 17:12:27  +0800</pubDate></item><item><title>Nimesulide ban a bitter blow for Hainan Honz</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>In the wake of the SFDA ban on the use of anti-inflammatory/anti-pyret......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 24 May 2011 16:40:36  +0800</pubDate></item><item><title>Stats for Shandong grassroots health system have positive implications</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Shandong Provincial Health Bureau has recently released statistica......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Tue, 24 May 2011 15:11:03  +0800</pubDate></item><item><title>Scatistical methods- MOH begins colorectal tumor registry for 2011</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Ministry of Health (MOH) recently issued a notice requiring medica......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Mon, 23 May 2011 17:25:37  +0800</pubDate></item><item><title>Jiangsu to transform level two hospitals into community health centers</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Nanjing Health Bureau recently announced that the government will ......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Mon, 23 May 2011 16:27:40  +0800</pubDate></item><item><title>SFDA pulls Almitrine-Raubasine (Duxil) based on Phase 4 studies</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The State Food and Drug Administration (SFDA) has recently issued a no......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Mon, 23 May 2011 15:08:01  +0800</pubDate></item><item><title>Tianjin eye hospital receives grant for pediatric cataract care</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>The Tianjin Eye Hospital has received a grant from Bausch + Lomb and t......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Mon, 23 May 2011 14:03:31  +0800</pubDate></item><item><title>SFDA halts pediatric nimesulide use</title><link>http://www.gbipharma.com/cpbsubscribe.asp</link><description>China health regulators have banned the use of anti-inflammatory/anti-......</description><author>GBIpharma.com</author><guid isPermaLink="false">http://www.gbipharma.com/cpbsubscribe.asp</guid><pubDate>Mon, 23 May 2011 13:58:40  +0800</pubDate></item></channel></rss>